|

Gemcitabine 1000 mg/m^2 Clinical Trials

2 actively recruiting trials across 2 locations

Pipeline

Phase 2: 1Phase 1/2: 1

Top Sponsors

  • Prestige Biopharma Limited1
  • Corcept Therapeutics1

Indications

  • Cancer2
  • Carcinoma, Pancreatic Ductal1
  • Adenocarcinoma1
  • Pancreatic Cancer1

Scottsdale, Arizona1 trial

Relacorilant With Nab-Paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Adenocarcinoma

Site 02

Phase 2

New Hyde Park, New York1 trial

First in Human Phase1/2a Clinical Trial of Anti-PAUF Monoclonal Antibody PBP1510 in Patients With Pancreatic Cancer

Northwell Health / R.J. Zuckerberg Cancer Center

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.